Research
Research, explained
Primary literature, summarized and cited.
Retatrutide phase 2: what the 2023 NEJM trial did and didn't show
A plain-language reading of the 48-week phase 2 obesity trial of an investigational triple-hormone receptor agonist.
Published 2026-10-11 · Last reviewed 2026-10-11 · Medical reviewer: pending assignment
How to read weight-loss trial numbers without being misled
Means, placebo adjustment, estimands, and why a trial average is not your personal forecast.
Published 2026-10-11 · Last reviewed 2026-10-11 · Medical reviewer: pending assignment